ClearVue Technologies (CPV) H2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2026 earnings summary
30 Sep, 2026Executive summary
FY26 focused on global project acquisition, product certification, and technology advancement, with key projects secured in Europe, Australia, and the Middle East.
Major product certifications achieved, including IEC and EN standards, enhancing market credibility and enabling broader deployment.
Strategic partnerships expanded in Asia, Middle East, and India, supporting commercialisation and manufacturing scale-up.
Leadership and board strengthened with new appointments, bringing technical and commercial expertise.
Financial highlights
Revenue for FY26 was $108,484, down from $249,925 in FY25.
EBITDA improved to $(8,534,226) from $(10,240,209) year-over-year.
Net loss after tax was $(11,861,917), slightly higher than $(11,584,706) in FY25.
Cash and cash equivalents at year-end were $4,420,700, up from $3,591,254.
No dividends declared or paid.
Outlook and guidance
Focus for the coming year is on execution: converting pipeline into commercial outcomes and demonstrating repeatable market adoption.
Continued investment in R&D and certification to maintain technology leadership.
Expansion into new markets, especially in Asia and Europe, is expected to drive growth.
Latest events from ClearVue Technologies
- Commercial deployments and certifications advanced, while quarter-end cash runway stood at 1.3 quarters.CPV
Q1 2027 - Solar façades target a USD 183B serviceable market through an asset-light model.CPV
Investor presentation - Surpassed cost reduction targets, advanced BIPV innovation, and expanded global partnerships.CPV
Investor presentation - Cost reductions, certifications, and global pipeline growth drive commercial momentum.CPV
Investor update - Commercialisation accelerated with global sales, expanded product range, and increased funding.CPV
H2 2024 - Revenue up 528% year-over-year with global expansion and new partnerships fueling growth.CPV
H2 2025 - Net loss narrowed as restructuring and Gen3 rollout set stage for future growth.CPV
H1 2026 - Licensee growth, product advances, and cost cuts support commercialisation and funding.CPV
Q2 2026 TU - Operational progress and new certifications set to drive revenue growth and market expansion.CPV
Status update